Report Detail
Global Zonisamide Market Insights, Forecast to 2025
- RnM3498612 |
- 06 June, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
The global Zonisamide market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Zonisamide market based on company, product type, end user and key regions.
This report studies the global market size of Zonisamide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Zonisamide in these regions.
This research report categorizes the global Zonisamide market by top players/brands, region, type and end user. This report also studies the global Zonisamide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Market size by Product
25mg
50mg
100mg
Market size by End User
Adult
Pediatric
Geriatric
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Zonisamide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Zonisamide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Zonisamide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Zonisamide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Zonisamide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Zonisamide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Zonisamide Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Zonisamide Market Size Growth Rate by Product
- 1.4.2 25mg
- 1.4.3 50mg
- 1.4.4 100mg
- 1.5 Market by End User
- 1.5.1 Global Zonisamide Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Pediatric
- 1.5.4 Geriatric
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Zonisamide Market Size
- 2.1.1 Global Zonisamide Revenue 2014-2025
- 2.1.2 Global Zonisamide Sales 2014-2025
- 2.2 Zonisamide Growth Rate by Regions
- 2.2.1 Global Zonisamide Sales by Regions
- 2.2.2 Global Zonisamide Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Zonisamide Sales by Manufacturers
- 3.1.1 Zonisamide Sales by Manufacturers
- 3.1.2 Zonisamide Sales Market Share by Manufacturers
- 3.1.3 Global Zonisamide Market Concentration Ratio (CR5 and HHI)
- 3.2 Zonisamide Revenue by Manufacturers
- 3.2.1 Zonisamide Revenue by Manufacturers (2014-2019)
- 3.2.2 Zonisamide Revenue Share by Manufacturers (2014-2019)
- 3.3 Zonisamide Price by Manufacturers
- 3.4 Zonisamide Manufacturing Base Distribution, Product Types
- 3.4.1 Zonisamide Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Zonisamide Product Type
- 3.4.3 Date of International Manufacturers Enter into Zonisamide Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Zonisamide Sales by Product
- 4.2 Global Zonisamide Revenue by Product
- 4.3 Zonisamide Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Zonisamide Breakdown Data by End User
6 North America
- 6.1 North America Zonisamide by Countries
- 6.1.1 North America Zonisamide Sales by Countries
- 6.1.2 North America Zonisamide Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Zonisamide by Product
- 6.3 North America Zonisamide by End User
7 Europe
- 7.1 Europe Zonisamide by Countries
- 7.1.1 Europe Zonisamide Sales by Countries
- 7.1.2 Europe Zonisamide Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Zonisamide by Product
- 7.3 Europe Zonisamide by End User
8 Asia Pacific
- 8.1 Asia Pacific Zonisamide by Countries
- 8.1.1 Asia Pacific Zonisamide Sales by Countries
- 8.1.2 Asia Pacific Zonisamide Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Zonisamide by Product
- 8.3 Asia Pacific Zonisamide by End User
9 Central & South America
- 9.1 Central & South America Zonisamide by Countries
- 9.1.1 Central & South America Zonisamide Sales by Countries
- 9.1.2 Central & South America Zonisamide Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Zonisamide by Product
- 9.3 Central & South America Zonisamide by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Zonisamide by Countries
- 10.1.1 Middle East and Africa Zonisamide Sales by Countries
- 10.1.2 Middle East and Africa Zonisamide Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Zonisamide by Product
- 10.3 Middle East and Africa Zonisamide by End User
11 Company Profiles
- 11.1 Concordia
- 11.1.1 Concordia Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Concordia Zonisamide Products Offered
- 11.1.5 Concordia Recent Development
- 11.2 Eisai
- 11.2.1 Eisai Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eisai Zonisamide Products Offered
- 11.2.5 Eisai Recent Development
- 11.3 Zydus Pharmaceuticals
- 11.3.1 Zydus Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Zydus Pharmaceuticals Zonisamide Products Offered
- 11.3.5 Zydus Pharmaceuticals Recent Development
- 11.4 Sun Pharma
- 11.4.1 Sun Pharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sun Pharma Zonisamide Products Offered
- 11.4.5 Sun Pharma Recent Development
- 11.5 Wockhardt
- 11.5.1 Wockhardt Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Wockhardt Zonisamide Products Offered
- 11.5.5 Wockhardt Recent Development
- 11.6 Mylan
- 11.6.1 Mylan Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Mylan Zonisamide Products Offered
- 11.6.5 Mylan Recent Development
- 11.7 APOTEX
- 11.7.1 APOTEX Company Details
- 11.7.2 Company Business Overview
- 11.7.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 APOTEX Zonisamide Products Offered
- 11.7.5 APOTEX Recent Development
- 11.8 Teva
- 11.8.1 Teva Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Teva Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Teva Zonisamide Products Offered
- 11.8.5 Teva Recent Development
- 11.9 Glenmark
- 11.9.1 Glenmark Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Glenmark Zonisamide Products Offered
- 11.9.5 Glenmark Recent Development
- 11.10 Bluepharma
- 11.10.1 Bluepharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Bluepharma Zonisamide Products Offered
- 11.10.5 Bluepharma Recent Development
- 11.11 Invagen Pharmaceuticals
- 11.12 Intas Pharmaceuticals
12 Future Forecast
- 12.1 Zonisamide Market Forecast by Regions
- 12.1.1 Global Zonisamide Sales Forecast by Regions 2019-2025
- 12.1.2 Global Zonisamide Revenue Forecast by Regions 2019-2025
- 12.2 Zonisamide Market Forecast by Product
- 12.2.1 Global Zonisamide Sales Forecast by Product 2019-2025
- 12.2.2 Global Zonisamide Revenue Forecast by Product 2019-2025
- 12.3 Zonisamide Market Forecast by End User
- 12.4 North America Zonisamide Forecast
- 12.5 Europe Zonisamide Forecast
- 12.6 Asia Pacific Zonisamide Forecast
- 12.7 Central & South America Zonisamide Forecast
- 12.8 Middle East and Africa Zonisamide Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Zonisamide Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Zonisamide . Industry analysis & Market Report on Zonisamide is a syndicated market report, published as Global Zonisamide Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Zonisamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
